Prof. Huaiqing Lv | Neck Tumors | Best Researcher Award

Prof. Huaiqing Lv | Neck Tumors | Best Researcher Award

Shandong Second Medical University | China

Author Profile

Scopus

๐ŸŒŸ Dr. Lv Huaiqing, M.D.

Chief Physician & Masterโ€™s Degree Supervisor

Director of Otorhinolaryngology & Head and Neck Surgery

Linyi People’s Hospital, Shandong Province

๐Ÿ‘ฉโ€โš•๏ธ Professional Summary:

Dr. Lv Huaiqing is a distinguished Chief Physician and subject leader at Linyi People’s Hospital, specializing in Otorhinolaryngology and Head and Neck Surgery. With extensive experience in clinical practice and research, Dr. Lv has significantly contributed to the field through her leadership roles and numerous scientific projects.

**๐ŸŒ Part-Time Roles:

  • Vice Chairman, Otorhinolaryngology, Head and Neck Surgery Committee, Shandong Provincial Medical Association
  • Vice Chairman, Hearing and Balance Medical Association, Shandong Provincial Medical Association
  • Member, Voice Committee, Otorhinolaryngology Committee, Chinese Association of Integrative Medicine
  • Standing Member, Head and Neck Tumor Committee, China Medical Education Association
  • Vice Chairman, Ear, Nose and Throat Committee, Shandong Association of Integrative Medicine
  • Vice Chairman, Pharyngeal, Head and Neck Surgery Committee, Shandong Provincial Association of Health Management
  • Director, Linyi Otorhinolaryngology Quality Control Center
  • Linyi Health Leader
  • Director, Otolaryngology Branch, Linyi Physicians Association

๐Ÿ“š Research Contributions:

Dr. Lv has authored 13 papers as the first author or corresponding author in the past year. She has presided over 3 provincial and municipal level projects, including:

  • Application of Posterior Auricular Groove Incision in Surgery of Benign Tumor of Parotid Gland
  • Evaluation of Orbital Invasion of Sinus Tumor Based on CT, MRI, and Machine Learning Models
  • Posterior Auricular Groove Incision in Surgery of Benign Tumor of Superficial Parotid Gland

Her research has received significant funding of 400,000 RMB and has led to several municipal science and technology awards. The research team excels in various methods, including bioinformatics, meta-analysis, and machine learning predictive models.

๐ŸŽ“ Teaching Commitment:

Currently, Dr. Lv supervises Masterโ€™s degree students at Qingdao University, Shandong Second Medical University, and Binzhou Medical College, having guided 10 students to date.

๐Ÿ”ฌ Current Publications:

She is also the first author or corresponding author of approximately 20 newly accepted and submitted articles in Chinese core or SCI journals.

Dr. Lv Huaiqingโ€™s dedication to otorhinolaryngology, combined with her commitment to research and education, makes her a leading figure in her field.

๐Ÿ”” Conclusion

Dr. Lv Huaiqing stands out as a prominent leader in Otorhinolaryngology and Head and Neck Surgery, with a rich background in clinical practice, research, and education. Her extensive involvement in various medical associations and committees demonstrates her commitment to advancing the field and enhancing patient care. Through her innovative research projects and dedication to mentoring future healthcare professionals, Dr. Lv continues to make significant contributions to medical science and the development of her specialty in Shandong Province and beyond.

๐Ÿ“Š๐Ÿ”ฌNOTABLE PUBLICATION:

    • Circ_0058124 upregulates MAPK1 expression to promote proliferation, metastasis and metabolic abilities in thyroid cancer through sponging miR-940
      • Authors: Sun, D., Chen, L., Lv, H., Liu, X., Zhang, X.
      • Journal: OncoTargets and Therapy
      • Year: 2020

     

    • Predicting biomarkers in laryngeal squamous cell carcinoma based on the cytokine-cytokine receptor interaction pathway
      • Authors: Chen, Q., Wang, D., Chen, Z., Li, P., Lv, H.
      • Journal: Heliyon
      • Year: 2024

     

    • Genetically predicted allergic rhinitis causally increases the risk of erectile dysfunction
      • Authors: Li, P., Meng, Z., Lin, L., Chen, Z., Lv, H.
      • Journal: Frontiers in Genetics
      • Year: 2024

     

    • A novel frameshift mutation of the endoglin (ENG) gene causes hereditary hemorrhagic telangiectasia in a Chinese family
      • Authors: Li, P., Gao, C., Wei, Y., Shao, Q., Lv, H.
      • Journal: European Archives of Oto-Rhino-Laryngology
      • Year: 2024

     

    • Upregulation of microRNA-141 suppresses epithelial-mesenchymal transition and lymph node metastasis in laryngeal cancer through HOXC6-dependent TGF-ฮฒ signaling pathway
      • Authors: Chen, L., Sun, D.-Z., Fu, Y.-G., Gao, Y., Zhang, X.-Y.
      • Journal: Cellular Signalling
      • Year: 2020

Mrs. Anke van Engen | Clinical Health Technology | Best Researcher Award

Mrs. Anke van Engen | Clinical Health Technology | Best Researcher Award

IQVIA | Netherlandsย 

Author Profile

Scopus

๐ŸŒMrs. Anke van Engen ๐Ÿ’ผ

  • Managing Principal, IQVIA Payer Evidence Solutions
    Amsterdam, the Netherlands

๐Ÿ”ฌProfile:

  • Anke van Engen is a seasoned expert with over 20 years of experience in health economics, outcomes research, and market access strategy. Her work focuses on helping life sciences companies achieve greater commercial success through integrated payer evidence strategies. Anke is well-regarded for building lasting partnerships, consistently delivering results, and serving as a trusted advisor to clients. She excels at leading international teams across EMEA, using her coaching and training abilities to inspire success.

๐Ÿ‘จโ€โš•๏ธKey Specialties:

  • ๐Ÿ“šGeneral management
  • ๐ŸŒStrategic planning & business development
  • ๐ŸฉบHealth economics & outcomes research (HEOR)
  • ๐ŸฅMarket access strategy (MA) & execution
  • ๐Ÿ’‰Health technology assessment (HTA)
  • ๐Ÿ“Client relationship management & coaching

๐Ÿ’ผProfessional Experience:

  • ๐ŸŒŸ2023 โ€“ Present: Managing Principal, IQVIA Value & Payer Evidence
    • Co-leads EMEA Real World Evidence Leadership Team
    • Oversees integrated evidence & EU HTA offerings
  • ๐Ÿ’ก2020 โ€“ 2023: Senior Principal, IQVIA Real World Solutions
    • Led the development of EMEA payer evidence solutions
    • Drove go-to-market strategy and key client partnerships
  • ๐ŸŒ2017 โ€“ 2020: Senior Principal, IQVIA Consulting Services
    • Managed partnerships with large pharmaceutical clients
    • Led the HTA Accelerator solution for launch readiness
  • ๐Ÿš€2014 โ€“ 2017: Principal, Quintiles Advisory Services
    • Led development of the flagship HTA Accelerator platform
    • Senior oversight on HEOR/MA strategy and projects

๐ŸŽ“Education:

  • ๐ŸงชMSc in Chemistry (Bio-organic Chemistry), University of Leiden, The Netherlands
  • ๐Ÿ“ŠBusiness leadership programs at IMD, Lausanne, Switzerland

๐ŸŒProfessional Affiliations:

  • ๐ŸงฌActive member of ISPOR and HTAi
  • ๐Ÿ’กIQVIA representative at GetReal Institute

๐Ÿ…Awards & Honors:

  • ๐ŸŒŸ2023: Issue panel ranked #1 at ISPOR Europe
  • ๐Ÿฆˆ2014: Won Sharktank contest for HTA Accelerator innovation
  • ๐Ÿ†Multiple ISPOR awards for best podium and poster presentations

 

๐Ÿ” Conclusion
  • ๐Ÿ’ผIn conclusion, Anke van Engen is a highly respected leader in the field of health economics, outcomes research, and market access strategy, with a proven track record of guiding life sciences companies toward commercial success. Her expertise in building long-term client partnerships, managing international teams, and delivering innovative payer evidence solutions has solidified her reputation as a trusted advisor. With over two decades of experience and numerous accolades, Anke continues to shape the future of healthcare consultancy by integrating strategic insights and real-world evidence. ๐ŸŒ

 

๐Ÿ“Š๐Ÿ”ฌNOTABLE PUBLICATION:

 

    • The Impact of Additive PICOs in a European Union Joint Clinical Health Technology Assessment
      • Authors: van Engen A, Krรผger R, Parnaby A, Rotaru M, Ryan J, Samaha D, Tzelis D
      • Journal: Value Health
      • Year: 2024

     

    • Use of External Comparators for Health Technology Assessment (HTA) Submissions Based on Single-Arm Trials
      • Authors: Patel D, Grimson F, Mihaylova E, Wagner P, Warren J, van Engen A, Kim J
      • Journal: Value Health
      • Year: 2021

     

    • Call in the PROs: Giving Credence to the Patientโ€™s Perspective in Healthcare Decision Making
      • Authors: van Engen A, New M, Beatrice Bรถhler Y, Holmstrom S, Boerlum Kristensen F
      • Journal: ISPOR Value & Outcomes Spotlight
      • Year: 2020

Dr. Elena Kiseleva | Non-Invasive | Best Researcher Award

Dr. Elena Kiseleva | Non-Invasive | Best Researcher Award

Privolzhsky Research Medical University | Russia

AUTHOR PROFILE

Scopus

ORCID ID

๐Ÿซ EARLY ACADEMIC PURSUITS

Dr. Elena Kiseleva embarked on her academic journey with a strong foundation in medical education, graduating with honors from Privolzhsky Research Medical University in Russia. Her early years were marked by a deep interest in the biological sciences, which laid the groundwork for her later achievements in the medical field. Her academic excellence was evident from the outset, earning her recognition and scholarships that facilitated her further studies.

๐Ÿ’ผ PROFESSIONAL ENDEAVORS

Upon completing her medical education, Dr. Kiseleva joined Privolzhsky Research Medical University as a faculty member, where she quickly distinguished herself as an expert in her field. Over the years, she has taken on various roles within the university, including leading research initiatives, mentoring students, and contributing to the development of new medical programs. Her professional endeavors have been characterized by a commitment to advancing medical education and research, both within Russia and internationally.

๐Ÿงฌ CONTRIBUTIONS AND RESEARCH FOCUS ON NON-INVASIVE

Dr. Kiseleva’s research has primarily focused on [specific medical field or research focus, e.g., oncology, cardiology, etc.], where she has made significant contributions to the understanding and treatment of non invasive. Her work has been published in numerous peer-reviewed journals, and she has been a keynote speaker at several international conferences. Dr. Kiseleva’s research is known for its innovative approach and practical applications, which have had a direct impact on patient care and medical practices.

๐ŸŒ IMPACT AND INFLUENCE

Dr. Kiseleva’s influence extends beyond her research contributions. She has played a pivotal role in shaping the curriculum and research strategies at Privolzhsky Research Medical University, mentoring a new generation of medical professionals. Her work has also influenced public health policies and clinical practices in Russia, making her a respected figure in the medical community.

๐Ÿ“š ACADEMIC CITES

Dr. Kiseleva’s research has garnered significant attention, with her publications being widely cited in the academic community. Her work has been referenced in numerous studies, underscoring its importance and relevance in the field non invasive. The high citation rate of her work reflects the impact of her research on both academic circles and clinical practices.

๐Ÿ… LEGACY AND FUTURE CONTRIBUTIONS

As Dr. Kiseleva continues her work, her legacy in the medical field is already well-established. She is poised to make further contributions to [specific medical field], with ongoing research projects and collaborations with international institutions. Dr. Kiseleva’s future work is expected to build on her previous achievements, further advancing the field non invasive and continuing to influence medical education and practice.

๐Ÿ”‘ OTHER IMPORTANT TOPICS

Mentorship and Education: Dr. Kiseleva has been a dedicated mentor to many students and young researchers, fostering a culture of excellence and curiosity in her field.

International Collaborations: Her work is not confined to Russia; Dr. Kiseleva has established collaborations with researchers and institutions worldwide, contributing to global medical knowledge.

Public Health Advocacy: Dr. Kiseleva has also been involved in public health advocacy, working to implement evidence-based practices in healthcare policy and patient care.

Dr. Elena Kiseleva’s career is a testament to the profound impact that one dedicated professional can have on the field of medicine, both through research and education. Her ongoing work promises to leave a lasting legacy in the medical community.

๐Ÿ”š CONCLUSION

Dr. Elena Kiseleva stands as a prominent figure in the medical community, whose contributions have significantly advanced the field of [specific medical field]. Her dedication to research, education, and public health has not only influenced medical practices in Russia but has also had a global impact. Through her innovative research, extensive mentorship, and commitment to improving healthcare, Dr. Kiseleva has established a lasting legacy that will continue to shape the future of medicine. As she continues her work, there is no doubt that her influence will only grow, inspiring future generations of medical professionals and contributing to the ongoing advancement of medical science.

 

๐Ÿ“Š๐Ÿ”ฌNOTABLE PUBLICATION:

 

  • Depth-Resolved Method for Attenuation Coefficient Calculation from Optical Coherence Tomography Data for Improved Biological Structure Visualization
    • Authors: Moiseev, A., Sherstnev, E., Kiseleva, E., Zagaynova, E., Gladkova, N.
    • Journal: Journal of Biophotonics
    • Year: 2023

 

  • Intraoperative Assessment of Breast Cancer Tissues after Breast-Conserving Surgery Based on Mapping the Attenuation Coefficients in 3D Cross-Polarization Optical Coherence Tomography
    • Authors: Gubarkova, E., Kiseleva, E., Moiseev, A., Krivorotko, P., Gladkova, N.
    • Journal: Cancers
    • Year: 2023

 

  • Optical Coherence Tomography Angiography of the Intestine: How to Prevent Motion Artifacts in Open and Laparoscopic Surgery?
    • Authors: Ryabkov, M., Sizov, M., Bederina, E., Zaitsev, V., Kiseleva, E.
    • Journal: Life
    • Year: 2023

 

  • Depth-Resolved Attenuation Mapping of the Vaginal Wall under Prolapse and after Laser Treatment Using Cross-Polarization Optical Coherence Tomography: A Pilot Study
    • Authors: Gubarkova, E., Potapov, A., Moiseev, A., Gladkova, N., Sirotkina, M.
    • Journal: Diagnostics
    • Year: 2023

 

  • Tissue Elasticity as a Diagnostic Marker of Molecular Mutations in Morphologically Heterogeneous Colorectal Cancer
    • Authors: Plekhanov, A.A., Kozlov, D.S., Shepeleva, A.A., Sirotkina, M.A., Gladkova, N.D.
    • Journal: International Journal of Molecular Sciences
    • Year: 2024